TREATMENT OF CHRONIC CUTANEOUS GRAFT VERSUS HOST DISEASE (GVHD) WITH OTOCHEMOTHERAPY WITH PSORALEN (PUVA): A REPORT OF FIVE CASES

Q: How can I download an article?

To download an article from SID, first log in to the site, search for the article title, and click on the 'Download Article' option.

Q: How can I download an ISI article?

To download an ISI article on SID, enter the keyword or article title in the search bar, view the relevant results, click on the desired article, and select the 'Download Article' option.

Q: How can I access the SID database?

To access the SID database, visit SID.ir, create an account, and log in to access scientific resources.

Q: Is downloading articles from SID free?

Some articles on SID are available for free, while others require payment. Details are specified on the article's page.

GHODSI SEYEDEH ZAHRA; BAHAR B.; RANJKESH M.; BALIGHI K.

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Journal Paper

Paper Information

Journal: Iranian Journal of Dermatology Year:2005 | Volume:8 | Issue:3 Page(s): 232-236

Download Full-Text

Persian Verion

View:

2,799

Download:

Cites:

Information Journal Paper

Title

TREATMENT OF CHRONIC CUTANEOUS GRAFT VERSUS HOST DISEASE (GVHD) WITH OTOCHEMOTHERAPY WITH PSORALEN (PUVA): A REPORT OF FIVE CASES

Author(s)

GHODSI SEYEDEH ZAHRA | BAHAR B. | RANJKESH M. | BALIGHI K. | Issue Writer Certificate

Keywords

GRAFT VERSUS HOST DISEASEQ4

PHOTOCHEMOTHERAPY WITH UVAQ4

PUVAQ4

Abstract

Chronic GRAFT VERSUS HOST DISEASE (GVHD) remains the most common late complication of allogenic stem cell transplantation and the most frequent cause of morbidity and mortality in these patients. To control this condition, ImmunosuppreSlve drugs are usually administered at a high dose and for a long time, which may result in several side effects. Five clinically and patients with histopathologically established cGVHD (3 lichenoid, 1 sclerodermoid and 1 mixed lichenoid-sclerodermoid) , who failed to respond to conventional immunosuppressive therapy were treated with psoralen and UVA (PUVA). Treatment was administered in a standard protocol three times a week on nonconsecutive days and were continued at least for 12 weeks. All 3 lichenoid cases showed complete improvement. In the sclerodermoid case there was partial response and in the mixed type case the partial response of sclerodermoid lesion and complete response of lichenoid lesions were observed. With the exception of a slight increase in liver tranferases, no other adverse reactions occurred. In conclusion, PUVA can be a safe and effective therapy in conjunction with systemic agents for chronic GVHD especially in lichenoid form.

Cites

No record.

References

No record.

Cite

APA: Copy

GHODSI, SEYEDEH ZAHRA, BAHAR, B., RANJKESH, M., & BALIGHI, K.. (2005). TREATMENT OF CHRONIC CUTANEOUS GRAFT VERSUS HOST DISEASE (GVHD) WITH OTOCHEMOTHERAPY WITH PSORALEN (PUVA): A REPORT OF FIVE CASES. IRANIAN JOURNAL OF DERMATOLOGY, 8(3), 232-236. SID. https://sid.ir/paper/57805/en

Vancouver: Copy

GHODSI SEYEDEH ZAHRA, BAHAR B., RANJKESH M., BALIGHI K.. TREATMENT OF CHRONIC CUTANEOUS GRAFT VERSUS HOST DISEASE (GVHD) WITH OTOCHEMOTHERAPY WITH PSORALEN (PUVA): A REPORT OF FIVE CASES. IRANIAN JOURNAL OF DERMATOLOGY[Internet]. 2005;8(3):232-236. Available from: https://sid.ir/paper/57805/en

IEEE: Copy

SEYEDEH ZAHRA GHODSI, B. BAHAR, M. RANJKESH, and K. BALIGHI, “TREATMENT OF CHRONIC CUTANEOUS GRAFT VERSUS HOST DISEASE (GVHD) WITH OTOCHEMOTHERAPY WITH PSORALEN (PUVA): A REPORT OF FIVE CASES,” IRANIAN JOURNAL OF DERMATOLOGY, vol. 8, no. 3, pp. 232–236, 2005, [Online]. Available: https://sid.ir/paper/57805/en

Related Journal Papers